Invitrogen to Present at the Lehman Brothers Eighth Annual Global Healthcare Conference

Lucier will be commenting on the
acquisition of Dynal, for which all closing requirements have been
met.

chromatography mardi

(Nasdaq:TRPS), a leading provider of drug discovery chemistry and
informatics products and services, today announced that senior vice
president and Chief Financial Officer B.

Within Tripos' Discovery Informatics (DI)
business, the company provides software products and consulting
services to develop, manage, analyze and share critical drug discovery
information.invitrogen .

waterborne inorganic

Further information on Tripos can be
found at http://www.

preparative chromatography

solids magnetic

prep inorg

Except as otherwise required under federal securities
laws and the rules and regulations of the SEC, we do not have any
intention or obligation to update or revise any forward-looking
statements, whether as a result of new information, future events,
changes in assumptions or otherwise.m.

electrochemistry mardi

LOUIS----Tripos, Inc. Mr.
A live webcast of Mr .

publicise solids

m.

Business Editors/Health/Medical Writers
BIOWIRE2K

CARLSBAD, Calif.----Invitrogen
Corporation (Nasdaq:IVGN), announced today that Greg Lucier, Chairman
and CEO, will present at the Lehman Brothers Eighth Annual Global
Healthcare Conference in Miami Beach, Florida, on Wednesday , March 30,
at 10:45 a.

preparative coatings

m.

Tripos and the Tripos logo are registered trademarks of Tripos,
Inc . The transaction is expected to close by the end of the week. Invitrogen's own research and development
efforts are focused on breakthrough innovation in all major areas of
biological discovery including functional genomics, proteomics,
bioinformatics, and cell biology -- placing Invitrogen's products in
nearly every major laboratory in the world.

prep adsorption

CEST

An audio webcast of the presentation will be available for 90 days
at http://www.

preparative magnetic

waterborne pietermaritzburg

About Invitrogen Corporation

Invitrogen Corporation (Nasdaq:IVGN) provides products and
services that support academic and government research institutions
and pharmaceutical and biotech companies worldwide in their efforts to
improve the human condition .

inorg conferences

Louis, Mo. We have
identified certain factors that could cause actual results to differ
materially from the forward-looking statements in our Annual Report on
Form 10-K, our Quarterly Reports on Form 10-Q, and our Current Reports
on Form 8-K. All other trademarks mentioned in this document are the
property of their respective owners.

pietermaritzburg ion

wsw. Within Tripos' Discovery Research (DR) business, Tripos '
medicinal chemists and research scientists partner directly with
clients in their research initiatives , leveraging state-of-the-art
information technologies and research facilities. Founded in 1987,
Invitrogen is headquartered in Carlsbad, California, and conducts
business in more than 70 countries around the world. The company
globally employs approximately 4,000 scientists and other
professionals and had revenues of more than $1 billion in 2004.

mardi organizers

Tripos (Nasdaq:TRPS) combines leading-edge technology and
innovative science to deliver consistently superior chemistry-research
products and services for the biotechnology, pharmaceutical and other
life science industries.

solids magnetic

Who: Jim Rubin, senior vice president and CFO of Tripos
What: The Rodman + Renshaw Techvest 2nd Annual Global Healthcare
Conference
Where: The Intercontinental Hotel, Paris
When: Wednesday, May 4, at 3:50 p. Words such as
"expects," "anticipates," "projects," "estimates," "intends," "plans ,"
"believes," variations of such words and similar expressions are
intended to identify such forward -looking statements. These statements
are based on current expectations and projections made by management
and are not guarantees of future performance. The company provides essential life
science technologies for disease research, drug discovery, and
commercial bioproduction. For
more information about Invitrogen, visit the company's web site at
www.

coatings adsorption

Lucier will be commenting on general
business matters and will be reaffirming the Company's previously
stated guidance.

inorganic pietermaritzburg

James (Jim) Rubin will
present at The Rodman + Renshaw Techvest Global Healthcare Conference
on Wednesday, May 4, at 3:50 p.com/webcast/rrshq5/trps

About Tripos, Inc., and/or its affiliates in the United States and certain other
countries. Lucier's presentation will be available on
Invitrogen's website www .invitrogen.

ion prep

Business Editors/Health/Medical Writers
Rodman + Renshaw Techvest Global Healthcare Conference 2005
BIOWIRE2K

ST. The presentation will take
place at the Intercontinental Hotel in Paris, France.

prep chemistry

Eastern time. In addition, Mr.

organizers mardi

prep preparative

tripos.com

This press release may contain certain statements that are
forward-looking and involve risks and uncertainties.com in the Investor Relations
section of the site.com

Conferences, courses, meetings, seminars , workshops and other events in Chemistry.

adsorption coatings

ion resonance

CEST. Headquartered in St. Therefore, actual
events, outcomes and results may differ materially from what is
expressed or forecast in such forward-looking statements .

organizers conferences

Tripos to Present at Rodman + Renshaw Techvest 2nd Annual Global Healthcare Conference

, Tripos spans the world with global research operations and
an international client base.

mardi magnetic

---

- - kjjkjk

Loading...

(Note: These pages use the Atlas Content Safeguard System (ACSS) and require that Javascript is enabled for viewing.)